PSMA radioligand therapy using 177Lu-PSMA I&T and 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer: comparison of safety, biodistribution and dosimetry
C. Schuchardt, J. Zhang, H. Kulkarni, X. Chen, D. Müller, R. Baum
{"title":"PSMA radioligand therapy using 177Lu-PSMA I&T and 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer: comparison of safety, biodistribution and dosimetry","authors":"C. Schuchardt, J. Zhang, H. Kulkarni, X. Chen, D. Müller, R. Baum","doi":"10.1055/s-0043-1766153","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":281512,"journal":{"name":"61. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin","volume":"107 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"61. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0043-1766153","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}